<i>In Vivo</i> Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model

Marguerite L. Monogue, David P. Nicolau, Sara Giovagnoli et al.|Antimicrobial Agents and Chemotherapy|2018

Cited by 55